GoodRx Holdings Inc [NASDAQ: GDRX] stock went on a downward path that fall over -18.58% on Thursday, amounting to a one-week price decrease of less than -19.89%.
Over the last 12 months, GDRX stock dropped by -19.79%. The one-year GoodRx Holdings Inc stock forecast points to a potential upside of 26.75. The average equity rating for GDRX stock is currently 2.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $2.63 billion, with 92.36 million shares outstanding and 77.28 million shares in the current float. Compared to the average trading volume of 1.40M shares, GDRX stock reached a trading volume of 6159593 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on GoodRx Holdings Inc [GDRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GDRX shares is $9.57 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GDRX stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for GoodRx Holdings Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on May 23, 2024. The new note on the price target was released on May 16, 2024, representing the official price target for GoodRx Holdings Inc stock. Previously, the target price had yet another raise to $9, while KeyBanc Capital Markets analysts kept a Overweight rating on GDRX stock. On March 25, 2024, analysts increased their price target for GDRX shares from 7.50 to 10.
The Average True Range (ATR) for GoodRx Holdings Inc is set at 0.58, with the Price to Sales ratio for GDRX stock in the period of the last 12 months amounting to 3.39. The Price to Book ratio for the last quarter was 4.16, with the Price to Cash per share for the same quarter was set at 1.40. Price to Free Cash Flow for GDRX in the course of the last twelve months was 20.69 with Quick ratio for the last quarter at 6.29.
GDRX Stock Performance Analysis:
GoodRx Holdings Inc [GDRX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -19.89. With this latest performance, GDRX shares dropped by -12.27% in over the last four-week period, additionally plugging by 12.70% over the last 6 months – not to mention a drop of -19.79% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GDRX stock in for the last two-week period is set at 32.85, with the RSI for the last a single of trading hit 26.33, and the three-weeks RSI is set at 37.65 for GoodRx Holdings Inc [GDRX]. The present Moving Average for the last 50 days of trading for this stock 8.26, while it was recorded at 8.25 for the last single week of trading, and 6.89 for the last 200 days.
Insight into GoodRx Holdings Inc Fundamentals:
GoodRx Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.29 and a Current Ratio set at 7.32.
GDRX Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GDRX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for GoodRx Holdings Inc go to 29.80%.
GoodRx Holdings Inc [GDRX] Institutonal Ownership Details
The top three institutional holders of GDRX stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in GDRX stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in GDRX stock with ownership which is approximately 5.1238%.
